Literature DB >> 2105215

Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1.

F Meggio1, D Shugar, L A Pinna.   

Abstract

5,6-Dichloro-1-(beta-D-ribofuranosyl)benzimidazole (DiCl-RB) is a powerful inhibitor of casein kinase-2 (CK-2) [Zandomeni, R. et al. (1986) J. Biol. Chem. 261, 3414-3420]. Here a series of 17 analogues of DiCl-RB has been employed for studying the specificity and the mode of action of this family of CK-2 inhibitors. The two halogen substituents on the benzene ring are shown to play a prominent role in inhibition, the 5,6-dibromo derivative (DiBr-RB) being fivefold more effective than DiCl-RB (Ki = 2 microM, with GTP as substrate), whereas the difluoro derivative (DiF-RB) is nearly as ineffective as unsubstituted 1-(beta-D-ribofuranosyl)benzimidazole. On the other hand, although some modifications of the ribose group significantly decrease the inhibitory efficiency, the sugar moiety is not strictly required, since dichlorobenzimidazole itself (DiCl-Bz) is an inhibitor almost as good as DiCl-RB. Inhibition of CK-2 by DiCl-RB and by its analogues, DiCl-Bz included, is of the competitive type with respect to the nucleotide substrate, the Ki values being lower with GTP than with ATP. The Ki values of the most potent inhibitor, DiBr-RB, with ATP and GTP, are 6 microM and 2 microM, respectively, denoting an affinity for the enzyme higher than that of the physiological substrates, ATP and GTP. DiBr-RB has been assayed for its inhibitory capacity toward several protein kinase other than CK-2. Protein kinase-C, cAMP-dependent protein kinase, the Ser/Thr protein kinase expressed by Pseudorabies virus, and four different tyrosine protein kinases from spleen, proved insensitive to DiBr-RB concentrations capable of almost entirely suppressing the activity of rat liver and maize seedling CK-2. Casein kinase-1 however is nearly as sensitive as CK-2 to DiBr-RB. Inhibition of CK-1 is also of the competitive type with respect to ATP (Ki = 14 microM). Although the inhibitory spectrum of CK-1 by the various analogues is reminiscent of that observed with CK-2, a remarkable difference is revealed by 5'-phosphorylation of ribose which increases the Ki with CK-2 while decreasing that with CK-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105215     DOI: 10.1111/j.1432-1033.1990.tb15280.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  22 in total

1.  The AP-3 complex required for endosomal synaptic vesicle biogenesis is associated with a casein kinase Ialpha-like isoform.

Authors:  V V Faundez; R B Kelly
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Casein Kinase II-Type Protein Kinase from Pea Cytoplasm and Its Inactivation by Alkaline Phosphatase in Vitro.

Authors:  S. Zhang; C. D. Jin; S. J. Roux
Journal:  Plant Physiol       Date:  1993-11       Impact factor: 8.340

3.  Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.

Authors:  Cameron N Johnstone; Perry S Mongroo; A Sophie Rich; Michael Schupp; Mark J Bowser; Andrew S Delemos; John W Tobias; Yingqiu Liu; Gregory E Hannigan; Anil K Rustgi
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

4.  A nuclear casein kinase 2 activity is involved in early events of transcriptional activation induced by salicylic acid in tobacco.

Authors:  P Hidalgo; V Garretón; C G Berríos; H Ojeda; X Jordana; L Holuigue
Journal:  Plant Physiol       Date:  2001-01       Impact factor: 8.340

5.  Identification of CK2 as the kinase that phosphorylates Pax3 at Ser209 in early myogenic differentiation.

Authors:  Aditi S Iyengar; Jacob M Loupe; Patrick J Miller; Andrew D Hollenbach
Journal:  Biochem Biophys Res Commun       Date:  2012-10-08       Impact factor: 3.575

6.  Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential.

Authors:  Giorgio Cozza; Cristina Girardi; Alessandro Ranchio; Graziano Lolli; Stefania Sarno; Andrzej Orzeszko; Zygmunt Kazimierczuk; Roberto Battistutta; Maria Ruzzene; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2014-01-18       Impact factor: 9.261

Review 7.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

Review 8.  Protein kinases phosphorylating acidic ribosomal proteins from yeast cells.

Authors:  R Szyszka
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

9.  Nucleocytoplasmic traffic disorder induced by cardioviruses.

Authors:  Peter V Lidsky; Stanleyson Hato; Maryana V Bardina; Alexei G Aminev; Ann C Palmenberg; Eugene V Sheval; Vladimir Y Polyakov; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.

Authors:  Kevin N Dietz; Patrick J Miller; Andrew D Hollenbach
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.